{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4796, 
        4810
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4863, 
        4877
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5035, 
        5049
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7734, 
        7757
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4711, 
        4738
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4646, 
        4650
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4830, 
        4834
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        845, 
        874
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4586, 
        4612
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4812, 
        4818
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4852, 
        4862
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5487, 
        5493
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5522, 
        5528
      ]
    }
  ], 
  "Neoplasm Descriptive Grade (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5009, 
        5034
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4637, 
        4642
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4678, 
        4683
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4687, 
        4698
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4743, 
        4748
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4786, 
        4795
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4823, 
        4828
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4979, 
        4984
      ]
    }, 
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Steven", 
      "__extent": [
        5453, 
        5464
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5494, 
        5505
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5529, 
        5543
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5775, 
        5780
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4666, 
        4673
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4971, 
        4978
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5767, 
        5774
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4614, 
        4616
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4643, 
        4645
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4663, 
        4665
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4684, 
        4686
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4699, 
        4701
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4740, 
        4742
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4820, 
        4822
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4968, 
        4970
      ]
    }, 
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Steven", 
      "__extent": [
        5450, 
        5452
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5507, 
        5509
      ]
    }
  ], 
  "Synoptic Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5545, 
        5562
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^44D1084007^CLIA|eMARCPlus|AL Cancer Registry|20170919125847||ORU^R01^ORU_R01|201709191258470001|P|2.5.1|AL||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-ES-011633^PathSys^44D1084007^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170823000000|||||||20170823000000|&Surg. Path Level V, Liver, Partial Resection, Colon, Segmental Resection for Tumor, Gallbladder, Surg. Path Level IV|1366657793^^^E^^^MD^^CMS^D^^^NPI||||||20170829000000|||F||||||C18.7^Malignant neoplasm of sigmoid colon^I10~C77.2^Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes^I10~C78.7^Secondary malignant neoplasm of liver and intrahepatic bile duct^I10~K76.0^Fatty (change of) liver, not elsewhere classified^I10~K76.89^Other specified diseases of liver^I10|1750607313&&&M.&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\nThe patient is \"\" identified by requisitions and container labels. 1. Specimen 1 is labeled \"segment 5 nodule liver\" on both the requisition and the container. Received fresh is a piece of tan tissue, 0.9 x 0.9 x 0.3 cm. There is a palpably firm area of gray discoloration, 0.3 cm in maximum dimension. A portion is examined as frozen section. The specimen is totally submitted. Section summary:   1FSA frozen section control.   1A, remaining tissue. 2. Specimen 2 is labeled \"left hepatectomy, suture at superior medial margin\" on both the requisition and the container. Received fresh is a 670 g portion of liver, 19.8 x 12.8 x up to 6.2 cm. A suture marks the superior medial margin. Prior to sectioning, the margin is inked blue. Sectioning reveals tan-brown to tan-red tissue. There is a firm white nodule, 2.3 x 2.1 x 1.5 cm, which grossly approaches to within approximately 1 cm of the closest resection margin. Further sectioning reveals no additional grossly identifiable lesions. Sectioning through the remainder of the specimen reveals no additional grossly identifiable lesions. Representative sections are processed. Section summary:   2A-D, lesion, sections include resected margins.   2E, grossly unaffected liver. 3. Specimen 3 is labeled \"sigmoid and colon\" on both the requisition and the container. Received fresh is a 33 cm segment of colon which displays up to 12 cm of attached fatty tissue over the serosa. There is no gross evidence of perforation. The serosa and attached fatty tissue display tattooing in the distal aspect of the specimen. The specimen includes mesorectum at the distal margin. The mesorectum appears intact. When opened, the specimen displays a lobular tan to tan-red tumor, 1.8 x 1.4 x up to 0.3 cm. The lesion grossly involves 1.3 cm of the mucosal circumference where the mucosal circumference is 4.0 cm. The lesion is 3.7 cm from the distal margin. The lesion is grossly 5.8 cm from the mesorectal margin. The lesion grossly involves the full thickness of the mucosa and submucosa and appears to extend into the muscularis propria. Extension into the adjacent fatty tissue is not grossly identified. Surgical staples are present at the distal margin. The proximal margin remains open. The remaining mucosa is tan and velvety and is grossly free of lesions. (JDM/HB4/ml3) Sectioning through the attached fatty tissue reveals 17 candidate lymph nodes, up to 0.5 cm in maximum dimension. Each is totally submitted. (JDM/HB4/ml3) Section summary:   3A, proximal margin   3B, distal margin   3C, mesorectal margin   3D-G, lesion, totally submitted   3H, 2 bisected candidate lymph nodes, differentiated by inks   3I-J, 15 candidate lymph nodes, each submitted whole (JDM/HB4/ml3) Following microscopic examination of the submitted tissue sections Dr. has requested that additional mesocolonic tissue be submitted for possibility of lymph node tissue. Representative pieces of mesocolon are submitted in cassette 3L-3U. JDM/MA5/ls12 4. Specimen 4 is labeled \"gallbladder\" on both the requisition and the container. Received in formalin is a collapsed gallbladder.  Dimensions: 9.8 x 3.9 cm, flattened. Serosa: Adherent fatty tissue. Mucosa: Dark green and velvety, no identifiable lesions. Wall Thickness: Up to 0.4 cm. Stones: None seen. Representative sections are processed in cassette 4A. 5. Specimen 5 is labeled \"donuts\" on both the requisition and the container. Received in formalin are 2 anastomotic rings, 1.0 and 1.1 cm in length, up to 2.0 cm in diameter. The specimens display tan velvety mucosal surfaces with no grossly identifiable lesions. Sectioning reveals suture material within the tissues. Representative sections are processed in cassette 5A.\n\n\nPath report.site of origin\n\n1. Segment five nodule liver 2. Left hepatectomy 3. Sigmoid and colon 4. Gallbladder 5. Donuts\n\n\nPath report.final diagnosis\n\n1. Liver nodule (segment five), excision:     Bile duct microhamartoma, benign. 2. Liver, left hepatectomy:     Metastatic adenocarcinoma; margins negative (0.5 cm from closest margin).     Background liver with mild steatosis. 3. Sigmoid colon, partial colectomy:     Moderately differentiated adenocarcinoma; poor treatment response (score 3).       -Size: 1.8 x 1.4 x 0.3 cm.       -Extent: Invades into but not through the muscularis propria.       -Lymph nodes: Eleven negative lymph nodes, three with evidence of         regressed tumor (0/11).       -Margins: Negative for tumor (closest 3.7 cm, distal).       -Mesorectum: Present distally, appears grossly intact.       -Pathologic stage: ypT2 N0 M1. 4. Gallbladder, cholecystectomy:     Benign gallbladder. 5. Donuts:     Benign colonic tissue. CANCER CHECKLIST: COLON AND RECTUM: Resection, Including Transanal Disk Excision of Rectal Neoplasms 3.000.001.1000043  Procedure: Sigmoidectomy  Macroscopic Intactness of Mesorectum (if applicable): Complete  Tumor Site: Sigmoid colon  Histologic Type: Adenocarcinoma  Histologic Grade: G2: Moderately differentiated  Tumor Size: Greatest dimension 1.8 cm  Tumor Deposits: Not identified  Tumor Extension: Tumor invades muscularis propria  Macroscopic Tumor Perforation: Not identified  Lymphovascular Invasion: Not identified  Perineural Invasion: Not identified  Tumor Budding: Number of tumor buds in one hotspot field (specify total number in area = 0.785 mm2) 2  Tumor Budding Score: Low score (0-4)  Type of Polyp in Which Invasive Carcinoma Arose: Tubular adenoma  Treatment Effect Absent: Extensive residual cancer with no evident tumor regression (poor or no response, score 3)  Margins: All margins are uninvolved by invasive carcinoma, high-grade dysplasia, intramucosal adenocarcinoma, and adenoma  Number of Lymph Nodes Involved: 0  Number of Lymph Nodes Examined: 11  TNM Descriptors: y (post-treatment)  Primary Tumor (pT): pT2: Tumor invades the muscularis propria  Regional Lymph Nodes (pN): pN0: No regional lymph node metastasis  Distant Metastasis (pM): pM1a: Metastasis to one site or organ is identified without peritoneal metastasis COLON AND RECTUM: Biomarker Reporting Template 1.001.001.1000043 Mismatch Repair  Immunohistochemistry (IHC) Testing for Mismatch Repair (MMR) Proteins: MLH1, MSH2, MSH6, PMS2, Background nonneoplastic tissue / internal control with intact nuclear expression  MLH1 Result: Intact nuclear expression  MSH2 Result: Intact nuclear expression  MSH6 Result: Intact nuclear expression  PMS2 Result: Intact nuclear expression  IHC Interpretation#: No loss of nuclear expression of MMR proteins: low probability of MSI-H  Microsatellite Instability (MSI): MSI-Stable (MSS)  KRAS Mutational Analysis: No mutation detected  NRAS Mutational Analysis: No mutation detected  BRAF Mutational Analysis: No mutations detected  Comment(s): Ancillary studies were performed on the previous material from the liver metastasis (4/21/17; 17-ES-5421).\n\n\nPath report.relevant Hx\n\nHistory - Secondary malignant neoplasm of liver and intrahepatic bile duct (C78.7), Malignant neoplasm of splenic flexure (C18.5)\n\n\n"
}